World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy!
JPD: Screening 4000 Literature, Parkinson's Disease, Psychiatric Symptom Presentation, What Are They?
Two-Drug Combination For Specific Mutation Colorectal Cancer With 100% Efficiency!
New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely!
Know Dementia, Know Alzheimer’s -Together, we can do so much
Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval
